Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New anxiolytic under development at Parke-Davis

Dec. 2, 1996

Antiepileptic agent reported by Parke-Davis

Dec. 2, 1996

Ethical's sustained-release morphine sublicensed for Canada

Dec. 2, 1996

CytoTherapeutics and Genentech sign new CNS therapeutics agreement

Nov. 29, 1996

Vertex compound effective in rat model of nerve injury

Nov. 29, 1996

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

Zeneca submits antimigraine Rx for approval

Nov. 28, 1996

Novel anticonvulsant described by SmithKline Beecham

Nov. 28, 1996

First approval for Aricept

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...